A new clinical trial found that adding mepolizumab to standard inhaled therapy significantly reduced moderate or severe COPD exacerbations in patients with high eosinophil counts, with a 21% lower annual rate and longer time to first flare.
A new study analyzed MRI data from over 200 participants to compare how corticosteroid and hyaluronic acid knee injections affect osteoarthritis progression, revealing distinct differences in joint deterioration over two years.
In a study of 66 postmenopausal women with vulvovaginal atrophy, platelet-rich plasma injections were associated with greater improvements in sexual function and comparable symptom relief to topical estrogen therapy.